ライフサイエンスコーパス: acquired immune deficiency syndrome

1 ed depletion of CD4(+) T cells that leads to acquired immune deficiency syndrome.

2 reverse transcriptase inhibitors (NRTIs) for acquired immune deficiency syndrome.

3 dying less often from progression of HIV to acquired immune deficiency syndrome.

4 bsence of CD4 T cells, as takes place during acquired immune deficiency syndrome.

5 e pathology of various malignancies in human acquired immune deficiency syndrome.

6 s (SIVE) in addition to immunodeficiency and acquired immune deficiency syndrome.

7 uses disseminated infection in patients with acquired immune deficiency syndrome.

8 n human immunodeficiency virus infection and acquired immune deficiency syndrome.

9 s known to be dysfunctional in patients with acquired immune deficiency syndrome.

10 infected humans underlies the development of acquired immune deficiency syndrome.

11 the development of antiviral agents against acquired immune deficiency syndrome.

12 immunosuppression and the development of the acquired immune deficiency syndrome.

13 tinitis pigmentosa, sickle cell disease, and acquired immune deficiency syndrome.

14 bone marrow transplant and in patients with acquired immune deficiency syndrome.

15 MV retinitis is facilitated in patients with acquired immune deficiency syndrome.

16 in 2 major epidemiologic studies of HIV and acquired immune deficiency syndrome.

17 n and the mechanisms of SIV- and HIV-induced acquired immune-deficiency syndrome.

18 ipheral T cell pool in select congenital and acquired immune deficiency syndromes.

19 an immunodeficiency virus (HIV) causes AIDS (acquired immune deficiency syndrome), a disease in which

20 and meninges from 17 macaques that developed acquired immune deficiency syndrome after infection with

21 portunistic infections characteristic of the acquired immune deficiency syndrome, ahs been reported i

22 d measurements for predicting progression to acquired immune deficiency syndrome (AIDS) and all-cause

23 Patients with acquired immune deficiency syndrome (AIDS) and boys with

24 TB is increasing due to its association with acquired immune deficiency syndrome (AIDS) and the emerg

25 Severe acute respiratory syndrome (SARS) and acquired immune deficiency syndrome (AIDS) are just two

26 pportunistic pathogen of human patients with acquired immune deficiency syndrome (AIDS) causing signi

27 r chemokines that is closely associated with acquired immune deficiency syndrome (AIDS) dementia, we

28 The acquired immune deficiency syndrome (AIDS) epidemic was

29 ivary gland tissues from 55 individuals with acquired immune deficiency syndrome (AIDS) for the prese

30 10 yrs, our perception of HIV infection and acquired immune deficiency syndrome (AIDS) has changed f

31 Diarrhea in patients with acquired immune deficiency syndrome (AIDS) has proven to

32 and CXCR4 in brain tissue from 20 pediatric acquired immune deficiency syndrome (AIDS) patients in r

33 mmon lethal opportunistic pathogen infecting Acquired Immune Deficiency Syndrome (AIDS) patients, and

34 sential for high-titer viral replication and acquired immune deficiency syndrome (AIDS) progression.

35 13%) met SCD criteria, 131 (57%) were due to acquired immune deficiency syndrome (AIDS), 25 (11%) wer

36 of co-infection on mortality from HIV and/or acquired immune deficiency syndrome (AIDS), and hepatiti

37 iagnosis mimicking Pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS), and that NSI

38 rticularly in immunocompromised persons with Acquired Immune Deficiency Syndrome (AIDS), and to the d

39 complication of human immunodeficiency virus/acquired immune deficiency syndrome (AIDS), but the mech

40 n 2001 on human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), effectively

41 disease, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), hepatitis C,

42 An animal model of acquired immune deficiency syndrome (AIDS), the simian i

43 n is a key pathogenic factor in a variety of acquired immune deficiency syndrome (AIDS)-associated di

44 Acquired immune deficiency syndrome (AIDS)-associated Ka

45 imate proportions, timing, and predictors of acquired immune deficiency syndrome (AIDS)-related and n

46 acaque monkeys develop immunosuppression and acquired immune deficiency syndrome (AIDS)-related infla

47 ted from 12 HIV-positive homosexual men with acquired immune deficiency syndrome (AIDS)-related KS (A

48 study, the presence of hydrolytic enzymes in acquired immune deficiency syndrome (AIDS)-related neuro

49 HIV+ male outpatients who had no history of acquired immune deficiency syndrome (AIDS)-related pulmo

50 with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).

51 d for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS).

52 he central nervous system (CNS) pathology of acquired immune deficiency syndrome (AIDS).

53 process that drives clinical progression to acquired immune deficiency syndrome (AIDS).

54 ectious disease epidemics, including that of acquired immune deficiency syndrome (AIDS).

55 ency virus and a small animal model of human acquired immune deficiency syndrome (AIDS).

56 c infectious agent observed in patients with acquired immune deficiency syndrome (AIDS).

57 ymerase chain reaction in KS associated with acquired immune deficiency syndrome (AIDS-KS), classical

58 HIV protease inhibitors in the treatment of acquired immune-deficiency syndrome (AIDS).

59 ion and alcoholism along with other factors (acquired immune deficiency syndrome [AIDS]-defining even

60 e elevated in the plasma of individuals with acquired immune deficiency syndrome and Kaposi sarcoma.

61 tes to the immunodeficiency of patients with acquired immune deficiency syndrome and suggest that mod

62 ptoms and human immunodeficiency virus (HIV)/acquired immune deficiency syndrome are complex and not

63 ation to the progressive immunodeficiency of acquired immune deficiency syndrome are controversial, p

64 se between pediatric and adult patients with acquired immune deficiency syndrome are most likely rela

65 mmunodeficiency virus type 1 (HIV-1) develop acquired immune deficiency syndrome-associated dementia

66 Acquired immune deficiency syndrome-associated Kaposi sa

67 e to seronegative controls and patients with acquired immune deficiency syndrome but without encephal

68 several neurodegenerative diseases including acquired immune deficiency syndrome dementia complex.

69 *5802-positive individual who presented with acquired immune deficiency syndrome despite repeatedly n

70 able efficacy in the rhesus macaque model of acquired immune deficiency syndrome, enabling 50% of vac

71 tein DNA/MVA vaccine can help to control the acquired immune deficiency syndrome epidemic.

72 The feline model of human acquired immune deficiency syndrome, feline immunodefici

73 mplicates human immunodeficiency virus (HIV)/acquired immune deficiency syndrome; however, liver path

74 other causes and occurrence of a particular acquired immune deficiency syndrome illness in human imm

75 In a single-center study, all HIV/acquired immune deficiency syndrome patients with comple

76 ciency virus encephalitis causes dementia in acquired immune deficiency syndrome patients.

77 gths of infection in 25% of immunosuppressed acquired immune deficiency syndrome patients.

78 oposed as a key agent in the pathogenesis of acquired immune deficiency syndrome related disorders, i

79 In an acquired-immune-deficiency-syndrome-related neoplasm, Ka

80 rium avium complex (MAC) among patients with acquired immune deficiency syndrome results from recent

81 , diabetes, and human immunodeficiency virus/acquired immune deficiency syndrome therapy, mechanical

82 ection and, potentially, as components of an acquired immune deficiency syndrome vaccine.

83 the previous 12 months and who did not have acquired immune deficiency syndrome were sequentially en

84 under conditions that reflect those seen in acquired immune deficiency syndrome, where this cell typ